Home
Resources
Publications
3-Deoxy-3,4-dehydro Analogs of XM462. Preparation and Activity on Sphingolipid Metabolism and Cell Fate

3-Deoxy-3,4-dehydro Analogs of XM462. Preparation and Activity on Sphingolipid Metabolism and Cell Fate

Luz Camacho, Fabio Simbari, Maria Garrido, José Luis Abad, Josefina Casas, Antonio Delgado, Gemma Fabriàs

Bioorg Med Chem. 2012 May 15;20(10):3173-9.

PMID: 22537678

Abstract:

Three analogs of the dihydroceramide desaturase inhibitor XM462 are reported. The compounds inhibit both dihydroceramide desaturase and acid ceramidase, but with different potencies depending on the N-acyl moiety. Other enzymes of sphingolipid metabolism, such as neutral ceramidase, acid sphingomyelinase, acid glucosylceramide hydrolase, sphingomyelin synthase and glucosylceramide synthase, are not affected. The effect on the sphingolipidome of the two best inhibitors, namely (R,E)-N-(1-hydroxy-4-(tridecylthio)but-3-en-2-yl)octanamide (RBM2-1B) and (R,E)-N-(1-hydroxy-4-(tridecylthio)but-3-en-2-yl)pivalamide (RBM2-1D), is in accordance with the results obtained in the enzyme assays. These two compounds reduce cell viability in A549 and HCT116 cell lines with similar potencies and both induced apoptotic cell death to similar levels than C8-Cer in HCT116 cells. The possible therapeutic implications of the activities of these compounds are discussed.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
IAR4243048	Dihydroceramide C8			Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: